{{Rsnum
|rsid=2230229
|Gene=TNFRSF10A
|Chromosome=8
|position=23191779
|Orientation=minus
|GMAF=0.1006
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=TNFRSF10A
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 69.0 | 28.3 | 2.7
| HCB | 97.0 | 3.0 | 0.0
| JPT | 96.5 | 3.5 | 0.0
| YRI | 73.1 | 26.2 | 0.7
| ASW | 71.9 | 28.1 | 0.0
| CHB | 97.0 | 3.0 | 0.0
| CHD | 99.1 | 0.9 | 0.0
| GIH | 94.1 | 5.9 | 0.0
| LWK | 84.4 | 13.8 | 1.8
| MEX | 82.5 | 14.0 | 3.5
| MKK | 85.1 | 14.9 | 0.0
| TSI | 77.5 | 21.6 | 1.0
| HapMapRevision=28
}}
{{PMID Auto
|PMID=19643596
|Title=TRAIL-R1 polymorphisms and cancer susceptibility: An evidence-based meta-analysis
}}

{{GET Evidence
|gene=TNFRSF10A
|aa_change=Arg441Lys
|aa_change_short=R441K
|impact=not reviewed
|qualified_impact=Insufficiently evaluated not reviewed
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs2230229
|overall_frequency_n=9151
|overall_frequency_d=10758
|overall_frequency=0.850623
|n_genomes=56
|n_genomes_annotated=0
|n_haplomes=98
|n_articles=0
|n_articles_annotated=0
|nblosum100=-3
|autoscore=0
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}